Litcius/Paper detail

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study

Emanuel Della‐Torre, Corrado Campochiaro, Giulio Cavalli, Giacomo De Luca, Angela Napolitano, Salvatore La Marca, Nicola Boffini, Valentina Da Prat, Gaetano Di Terlizzi, Marco Lanzillotta, Patrizia Rovere‐Querini, Annalisa Ruggeri, Giovanni Landoni, Moreno Tresoldi, Fabio Ciceri, Alberto Zangrillo, Francesco De Cobelli, Lorenzo Dagna

2020Annals of the Rheumatic Diseases244 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePneumoniaInternal medicineNeutropeniaSurgeryGastroenterologyToxicityCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Pneumothorax, Barotrauma, Emphysema
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study | Litcius